Discontinuation report ACT IRBESARTAN/HCT

Last updated on 2018-10-19 History
Report ID 65074
Drug Identification Number 02357410
Brand name ACT IRBESARTAN/HCT
Common or Proper name IRBESARTAN/HCT
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s)
Strength(s)
Dosage form(s)
Route of administration
Packaging size 100
ATC code
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-02-28
Remaining supply date 2018-02-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Transitioned. TEVA available
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-10-19 French Compare
v1 2018-10-19 English Compare